Journal of Neurochemistry · 2001 · 33 citations · 14 references
MedicineCancer BiologyOncologyCancer PharmacologyMolecular OncologyNeuro-oncologyCancer Cell SignalingCentral Nervous System Tumor PharmacotherapyGlioblastomaMalignant NeoplasmsOncology PharmacologySignal Transduction In CancerCancer Cell Proliferation InhibitionCell MorphologyCell Morphology AnalysisGlioblastoma Drug TherapyGlioblastoma Gene TherapyGlioblastoma Tumor Biology
We describe here the oncostatin M (OSM)-dependent inhibition of in vivo tumour formation after intracerebral inoculation of glioblastoma cells in mice. We generated human glioblastoma cells transfected with the OSM gene under the control of a tetracycline-response promoter. Upon removal of tetracycline from the medium, cells exhibited a differentiated cell morphology, while proliferation was significantly inhibited. After implantation of these cells into nude mice brains, large tumours developed in animals lacking OSM expression, whereas no tumour formation was observed in mice with induced OSM expression. Our results suggest that OSM exerts pronounced antitumorigenic effects on glioblastoma cells in vivo and provide arguments for a therapeutic application of OSM in humans.
14
Gene therapy of experimental brain tumors using neural progenitor cells
Sara Benedetti, Barbara Pirola, Bianca Pollo et al. · Nature Medicine · 2000 · 456 citations
Medicine, Neuroscience, Oncology +16
Dual Oncostatin M (OSM) Receptors
Bruce Mosley, Cyr De Imus, Della Friend et al. · Journal of Biological Chemistry · 1996 · 388 citations · Full text
Regulation of Cell Growth by Recombinant Oncostatin M
Diane Horn, William C. Fitzpatrick, Peter T. Gompper et al. · Growth Factors · 1990 · 116 citations
Medicine, Cell Biology, Oncology +8